Overview

The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy

Status:
Completed
Trial end date:
2018-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate exploratorily the effect of ramelteon 8 mg once daily for 8 weeks in the treatment of insomnia patients with depression by using actigraphy.
Phase:
Phase 4
Details
Lead Sponsor:
Takeda